NCT01087424View on ClinicalTrials.gov

Mini-CHOP and Rituximab in Patients Aged Over 80 Years

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Diffuse Large B-Cell Lymphoma
Interventions
DRUG

R mini CHOP

Prednisone 40 mg/m2 D1 D2 D3 D4 D5 Rituximab 375 mg/m2 D1 Doxorubicine 25 mg/m2 D1 Cyclophosphamide 400 mg/m2 D1 Vincristine 1 mg/m2 D1

All Listed Sponsors
lead

Lymphoma Study Association

OTHER

NCT01087424 - Mini-CHOP and Rituximab in Patients Aged Over 80 Years | Biotech Hunter | Biotech Hunter